Scripps Translational Science Institute

About:

Scripps Translational Science Institute works to translate the latest advances in genomics into new diagnostics and treatments.

Website: http://www.stsiweb.org/

Top Investors: National Institutes of Health

Description:

Scripps Translational Science Institute works to translate the latest advances in genomics into new diagnostics and treatments. In collaboration with Scripps Genomic Medicine, STSI researchers have collected DNA to generate a comprehensive human DNA bank. These samples could help identify genetic markers for cardiovascular disease, breast, colon and prostate cancers. and other conditions. STSI and Scripps Genomic Medicine investigators have also partnered with Affymetrix, Microsoft, and Navigenics to determine whether personal genomic testing motivates people to make positive lifestyle changes.

Total Funding Amount:

$34M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

La Jolla, California, United States

Founded Date:

2006-01-01

Contact Email:

STSI(AT)scripps.edu

Founders:

Eric Topol

Number of Employees:

11-50

Last Funding Date:

2018-05-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai